Journal for ImmunoTherapy of Cancer (Feb 2022)
Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma
- Makoto Tahara,
- Ranee Mehra,
- Kei Muro,
- Bhumsuk Keam,
- Mark Ayers,
- Robin Mogg,
- Razvan Cristescu,
- Jared Lunceford,
- Andrew Albright,
- Jonathan Cheng,
- Barbara Burtness,
- Shilpa Gupta,
- Hyunseok Kang,
- Laura Q M Chow,
- Lingkang Huang,
- Joseph P Eder,
- Jared Weiss,
- Robert I Haddad,
- Tanguy Y Seiwert,
- Iris Gluck
Affiliations
- Makoto Tahara
- Aff4 grid.272242.30000000121685385National Cancer Center Hospital East Kashiwa Japan
- Ranee Mehra
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA
- Kei Muro
- Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan
- Bhumsuk Keam
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea
- Mark Ayers
- Aff218 grid.417993.10000000122600793Merck & Co., Inc. West Point PA USA
- Robin Mogg
- Aff219 grid.417993.10000000122600793Merck & Co., Inc. Kenilworth NJ USA
- Razvan Cristescu
- Merck & Co, Inc, Kenilworth, New Jersey, USA
- Jared Lunceford
- Merck & Co, Inc, Kenilworth, New Jersey, USA
- Andrew Albright
- Merck & Co, Inc, Kenilworth, New Jersey, USA
- Jonathan Cheng
- Aff244 grid.417993.10000000122600793Merck & Co., Inc. Kenilworth NJ USA
- Barbara Burtness
- Aff8 grid.47100.320000000419368710Yale University School of Medicine New Haven CT USA
- Shilpa Gupta
- Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA
- Hyunseok Kang
- University of California, San Francisco, San Francisco, CA, USA
- Laura Q M Chow
- Department of Oncology, University of Texas at Austin, Dell Medical School, Austin, Texas, USA
- Lingkang Huang
- 3 Merck & Co., Inc, Kenilworth, New Jersey, USA
- Joseph P Eder
- Early Drug Development, Yale Cancer Institute, New Haven, Connecticut, USA
- Jared Weiss
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA
- Robert I Haddad
- Department of Medical Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA
- Tanguy Y Seiwert
- Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, USA
- Iris Gluck
- Department of Oncology, Sheba Medical Center at Tel HaShomer, Ramat Gan, Israel
- DOI
- https://doi.org/10.1136/jitc-2021-003026
- Journal volume & issue
-
Vol. 10,
no. 2
Abstract
No abstracts available.